A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  American Journal on Addictions

• Publication date

  2016-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/ajad.12346PMID 26894822PMCID PMC4791182
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Topiramate in Alcohol Use Disorders: Review and Update

  2015cited by this paper
• Low-Dose Topiramate in Alcohol Dependence: A Single-Blind, Placebo-Controlled Study

  2014cited by this paper
• A randomized, double‐blind, placebo‐controlled clinical trial of acamprosate in alcohol‐dependent individuals with bipolar disorder: a preliminary report

  2012cited by this paper
• The role and interpretation of pilot studies in clinical research.

  2011cited by this paper
• Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials.

  2009cited by this paper
• Topiramate for treating alcohol dependence: a randomized controlled trial.

  2007cited by this paper
• Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.

  2006cited by this paper
• Does recovery from substance use disorder matter in patients with bipolar disorder?

  2005influential reference
• Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.

  2005influential reference
• Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.

  2003cited by this paper
• Timeline Follow-Back A Technique for Assessing Self-Reported Alcohol Consumption

  1992cited by this paper
• A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism.

  1987cited by this paper

• Quality of life assessment instruments used in clinical trials for alcohol use disorder: A systematic review.

  2025cites this paper
• Navigating the challenges of substance use and psychopathology in depression, bipolar disorder, and schizophrenia.

  2025cites this paper
• A Double-Blind, Placebo-Controlled Study of Adjunctive Topiramate in Adolescents With Co-Occurring Bipolar and Cannabis Use Disorders

  2024cites this paper
• A Bayesian meta-analysis of topiramate’s effectiveness for individuals with alcohol use disorder

  2023cites this paper
• Transferability and sustainability of process-based multi-task adaptive cognitive training in community-dwelling older adults with mild cognitive impairment: a randomized controlled trial

  2023cites this paper
• Meta-analysis of the effects of adjuvant drugs in co-occurring bipolar and substance use disorder.

  2023cites this paper
• Triple Diagnosis of Attention-Deficit/Hyperactivity Disorder with Co-existing Bipolar and Alcohol Use Disorders: Clinical Aspects and Pharmacological Treatments

  2022cites this paper
• The pharmacotherapeutic management of comorbid bipolar disorder and alcohol use disorder

  2022cites this paper
• Comorbid Bipolar and Alcohol Use Disorder—A Therapeutic Challenge

  2021cites this paper
• Treatment of Comorbid Psychiatric Disorders with Bipolar Disorder

  2021cites this paper
• A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder

  2021cites this paper
• Pharmacological Treatment of Mood Disorders and Comorbid Addictions: A Systematic Review and Meta-Analysis: Traitement Pharmacologique des Troubles de L’humeur et des Dépendances Comorbides: Une Revue Systématique et une Méta-Analyse

  2020cites this paper
• Preliminary findings on topiramate for addressing health behaviors in comorbid bipolar disorder and alcohol use disorder.

  2020cites this paper
• Trastornos del ánimo y trastornos por uso de sustancias: una comorbilidad compleja y frecuente

  2020cites this paper
• A Population Pharmacokinetic Analysis of PF-5190457, a Novel Ghrelin Receptor Inverse Agonist in Healthy Volunteers and in Heavy Alcohol Drinkers

  2020cites this paper
• Alcoholism in Bipolar Disorders: An Overview of Epidemiology, Common Pathogenetic Pathways, Course of Disease, and Implications for Treatment

  2019cites this paper
• Pharmacotherapies for co‐occurring substance use and bipolar disorders: A systematic review

  2019cites this paper
• Alkoholkonsumstörungen und Suizidalität: Ein narratives Review

  2019cites this paper
• In Vitro Drug Metabolism and Population Pharmacokinetics as Tools for Elucidating Pharmacokinetic Variability

  2018cites this paper
• Practical outpatient pharmacotherapy for alcohol use disorder

  2018cites this paper
• No differences in manic-like behaviors between voluntary ethanol and water drinking in Lateral Hypothalamic Kindled (LHK) alcohol preferring rats.

  2018cites this paper
• Older age bipolar disorder and substance use

  2017cites this paper
• Management of comorbid bipolar disorder and substance use disorders

  2017cites this paper
• Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial Design

  2017cites this paper
• Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder

  2017cites this paper
• Unique prefrontal GABA and glutamate disturbances in co-occurring bipolar disorder and alcohol dependence

  2017cites this paper
• Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

  2016cites this paper
• Komorbidität affektiver Erkrankungen und alkoholbezogener Störungen

  2016cites this paper
• The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm

  2016cites this paper